0001610618-24-000025.txt : 20240320 0001610618-24-000025.hdr.sgml : 20240320 20240320184741 ACCESSION NUMBER: 0001610618-24-000025 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240315 FILED AS OF DATE: 20240320 DATE AS OF CHANGE: 20240320 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Tari Leslie CENTRAL INDEX KEY: 0001870270 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36912 FILM NUMBER: 24768982 MAIL ADDRESS: STREET 1: C/O CIDARA THERAPEUTICS, INC. STREET 2: 6310 NANCY RIDGE DR SUITE 101 CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cidara Therapeutics, Inc. CENTRAL INDEX KEY: 0001610618 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 461537286 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6310 NANCY RIDGE DRIVE STREET 2: SUITE 101 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-752-6170 MAIL ADDRESS: STREET 1: 6310 NANCY RIDGE DRIVE STREET 2: SUITE 101 CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: K2 THERAPEUTICS, INC. DATE OF NAME CHANGE: 20140611 4 1 wk-form4_1710974846.xml FORM 4 X0508 4 2024-03-15 0 0001610618 Cidara Therapeutics, Inc. CDTX 0001870270 Tari Leslie 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121 0 1 0 0 CHIEF SCIENTIFIC OFFICER 0 Common Stock 2024-03-15 4 A 0 111250 0 A 369931 D Common Stock 1484 I By spouse Employee Stock Option (right to buy) 0.6849 2024-03-15 4 A 0 222500 0 A 2034-03-14 Common Stock 222500 222500 D Represents time-based Restricted Stock Units (RSUs) granted on March 15, 2024. All RSUs vest in three equal annual installments, with 1/3 vesting on each of March 10, 2025, 2026, and 2027, subject to continuous service through each such vesting date. The option shall vest and become exercisable in a series of thirty-six (36) successive equal monthly installments measured from the Vesting Commencement Date of March 15, 2024. /s/ Shane Ward, Attorney-in-Fact 2024-03-20